According to a newly published market research report by 24LifeSciences, global Triage B-Type Natriuretic Peptide Testing market was valued at USD 786.2 million in 2023 and is projected to reach USD 1.24 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2024–2030. Triage B-Type Natriuretic Peptide Testing is a critical diagnostic...

The United States Natriuretic Peptide Market represents the largest share of the North American region, supported by the country's high burden of cardiovascular disorders and strong focus on preventive healthcare. Increasing utilization of BNP and NT-proBNP tests for the diagnosis, prognosis, and monitoring of heart failure is contributing to sustained market growth. The presence of leading...